UCL HUNTINGTON’S DISEASE RESEARCH

INFORMATION FOR SCIENTISTS, CLINICIANS, PATIENTS, RELATIVES AND CARERS

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial, led by UCL Huntington’s Disease Centre, and successfully lowered the level of the harmful huntingtin protein in the nervous system.

 

https://www.ucl.ac.uk/news/news-articles/1217/111217-huntingtons-disease-protein

All press queries should be directed to j.behagg@ucl.ac.uk.

Updated December 11, 2017